Form 8-K - Current report:
SEC Accession No. 0001493152-24-046545
Filing Date
2024-11-18
Accepted
2024-11-18 16:45:36
Documents
17
Period of Report
2024-11-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 52936
2 ex1-1.htm EX-1.1 269522
3 ex99-1.htm EX-99.1 15942
4 ex99-2.htm EX-99.2 13895
  Complete submission text file 0001493152-24-046545.txt   598925

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE iztc-20241114.xsd EX-101.SCH 3015
6 XBRL LABEL FILE iztc-20241114_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE iztc-20241114_pre.xml EX-101.PRE 24165
20 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3780
Mailing Address 750 ROYAL OAKS DR MONROVIA CA 91016
Business Address 750 ROYAL OAKS DR MONROVIA CA 91016 (626) - 415 - 1488
Invizyne Technologies Inc (Filer) CIK: 0002010788 (see all company filings)

EIN.: 834550057 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42204 | Film No.: 241472082
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)